The long-term effect of quetiapine (Seroquel^TM) monotherapy on weight in patients with schizophrenia

By Brecher M   Rak I.W.   Melvin K   Jones A.M.  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 4, 2000-12 ,pp. : 287-291

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

By Lee Phil   Eung Kim Chul   Yoon Kim Chang   Lin Wei-Wen   Habil Hussain   Dyachkova Yulia   Mcbride Margaret   Dossenbach Martin  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 215-227

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Quetiapine demonstrates good tolerability and is associated with improvements in extrapyramidal symptoms in patients with schizophrenia switched from other antipsychotics: results of a naturalistic study

By Hellewell Jonathan S. E.  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 2, 2007-01 ,pp. : 112-122

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term assessment of the efficacy and tolerability of risperidone in early schizophrenia: An international multicenter study

By Rybakowski Janusz K.   Jarema Marek  

International Journal of Psychiatry in Clinical Practice, Vol. 8, Iss. 3, 2004-09 ,pp. : 147-152

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report

By Reznik I   Benatov R   Sirota P  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 1, 2000-03 ,pp. : 77-80

Ashgate Publishing Ltd

Access to resources Recommend Favorite